Stemline Therapeutics
- Partner Level
- Diamond
- Company Headquarters
- 750 Lexington Ave., 11th Floor, New York, NY 10022
- Phone
- 877-332-7961
- Website
- Visit Site
Overview
Company Overview
Stemline Therapeutics, a part of the Menarini Group, is focused on the development and commercialization of novel oncology therapeutics.
The goal of our dedicated team of scientists, specialists, researchers, and developers is to build a leading biopharmaceutical company focused on improving the lives of cancer patients by developing and commercializing novel first-in-class therapeutics.
Mission/Beliefs/Values
To build a leading commercial stage biopharmaceutical company focused on improving the lives of cancer patients by developing and marketing innovative oncology therapeutics that target difficult-to-treat cancers.
Hematologic Cancer
Hematologic Cancer
BPDCN is a cancer that affects your blood and the soft tissue inside your bones, which is called bone marrow. It can also affect other parts of your body, such as your lymph nodes, spleen, central nervous system, and skin. Learn more about this hematologic disease at http://BPDCNinfo.com.
Metastatic Breast Cancer
Metastatic Breast Cancer
Nearly 1 out of 2 people with ER+/HER2- metastatic breast cancer may develop an ESR1 mutation after progression on hormone therapy. Learn more about this ESR1 mutation at http://Knowesr1.com.
